The Institute of Biomedical Research of Salamanca strengthens its scientific leadership by supporting the hospital’s inclusion in the EUnetCCC network, focused on excellence and coordination in cancer care.
The Institute of Biomedical Research of Salamanca (IBSAL) has played a key role in the inclusion of the Salamanca University Hospital in major European initiatives for excellence in oncology. Thanks to close collaboration between the hospital and IBSAL, the Salamanca complex has been part of the EU CraNE plan since late 2024. The plan connects 45 Comprehensive Cancer Centres (CCCs) across Europe.
In December 2024, the CraNE plan—also known as EUnetCCC—was officially launched by the European Commission. Its goal is to create a network of Comprehensive Cancer Centres to foster the sharing of best practices, resources, and expertise among Europe’s leading cancer hospitals. IBSAL has been instrumental in this process, contributing scientific expertise and helping Salamanca join this network of excellence.
The project ‘The European Comprehensive Cancer Centre Network (EUnetCCC)’ is funded by the European Union under the EU4Health programme, managed by the European Health and Digital Executive Agency (HaDEA), Grant Agreement No. 101183407.
Earlier, in late 2023, the Salamanca University Hospital had already been selected as a member of an elite network of comprehensive cancer centres, marking the beginning of its journey toward European accreditation.
With IBSAL’s ongoing support, the hospital aligns with the strategy set by the CraNE/EUnetCCC Joint Action, which aims for 90% of cancer patients in the EU to be treated in accredited Comprehensive Cancer Centres by 2030.
This milestone highlights IBSAL’s pivotal role in advancing biomedical research and enhancing cancer care. It also opens up new training and collaboration opportunities with other European centres, reinforcing Salamanca’s position as a benchmark in translational cancer research.
Source: La Gaceta de Salamanca: El Hospital pasa a formar parte de la ‘red VIP’ de los centros oncológicos de Europa and El Hospital activa el plan CraNE: la red europea de centros de excelencia para la atención integral del cáncer
